Pfizer CEO pushes back against former CDC head over vaccine IP rights


You Might Also Like

– Advertisement –

Pfizer CEO Albert Boerla discusses COVID-19 booster shots

– Advertisement –

Pfizer CEO Albert Boerla on Sunday pushed back against calls to waive the company’s intellectual property rights for its COVID-19 vaccine, which critics claim would speed up vaccine distribution in poor countries.

Bourla defended intellectual property rights on ABC’s “This Week” when Tom Frieden, the former head of the Centers for Disease Control and Prevention, slammed Pfizer and Moderna, saying the two companies were “providing expensive vaccines to rich countries” rather than shutting down. focusing on selling. Global gap in vaccine supply.


COVID-19 Vaccine Booster Could Mean Billions for Drugmakers

“Intellectual property created a thriving life sciences sector that was ready when the pandemic hit,” borla said. “Without it, we wouldn’t be here to discuss whether or not we need boosters because we wouldn’t have vaccines.”

– Advertisement –

Borla also said that the US government recently bought 1 billion vaccine doses in an agreement with the company, and they donate those doses to poor countries at no cost.

“There is no other company that can claim that we have done so much good for humanity,” Borla said, calling Frieden’s comments “unfair.”

anchor the protection The last Change Change %
PFE Pfizer Inc. 43.94 -0.25 -0.57%

He said he believed the world could return to “normal life” within a year, although vaccinations would still be needed as new versions are likely to arrive around the world.

Boura said that future vaccines to fight these new types could last at least a year.

Get Granthshala Business on the go by clicking here

Last week, Pfizer announced that its vaccine is safe for children 5 to 11.

Borla said the company will submit its data to the FDA within a few days, and that Pfizer has the manufacture to produce this form of the vaccine once the agency approves it.

– Advertisement –

Related News

Next Post

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending News